The Cathepsin D (224C/T) polymorphism confers an increased risk to develop alzheimer's disease in men

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 65 A, Issue 3, 2010, Pages 219-224

  Albayrak, O ^a   Tirniceriu, A ^b   Riemenschneider, M ^c   Kurz, A ^d   Scherag, A ^e   Egensperger, Rupert ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Cathepsin; Dementia; Gender; Genetics; Risk factor

Indexed keywords

CATHEPSIN D; DNA;

AGE; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COMPARATIVE STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; GERMANY; HUMAN; INCIDENCE; MALE; METABOLISM; POLYMERASE CHAIN REACTION; PROGNOSIS; RISK FACTOR;

AGE FACTORS; AGED; ALLELES; ALZHEIMER DISEASE; CATHEPSIN D; DNA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; HUMANS; INCIDENCE; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS;

EID: 77949533379     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glp209     Document Type: Article

References (40)

1. Aguzzi A, Haass C. Games played by rogue proteins in prion disorders and Alzheimer's disease. Science. 2003;302:814-818.
2. Nixon RA, Cataldo AM, Paskevich PA, Hamilton DJ, Wheelock TR, Kanaley-Andrews L. The lysosomal system in neurons: involvement at multiple stages of Alzheimer's disease pathogenesis. In Banner CDB, Nixon RA, eds. Proteases and Protease Inhibitors in Alzheimer's Disease Pathogenesis. New York: New York Academy of Sciences; 1992;674:S103-S117.
3. Reid WA, Valler MJ, Kay J. Immunolocalization of cathepsin D in normal and neoplastic human tissues. J Clin Pathol. 1986;39:1323-1330.
4. Kirschke H, Barrett AJ. Chemistry of lysosomal proteases. In: Glaumann H and Ballard FJ (eds). Lysosomes: Their Role in Protein Breakdown. London, UK: Academic Press; 1997:193-238.
5. Cataldo AM, Thayer CY, Bird ED, Wheelock TR, Nixon RA. Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin. Brain Res. 1990;513:181-192.
6. Nakamura Y, Takeda M, Suzuki H et al. Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease. Neurosci Lett. 1991;130:195-198.
7. Hoffman KB, Bi X, Pham JT, Lynch G. Beta-amyloid increases cathepsin D levels in hippocampus. Neurosci Lett. 1998;250:75-78.
8. Cataldo AM, Barnett JL, Berman SA, et al. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron. 1995;14:671-680.
9. Papassotiropoulos A, Bagli M, Feder O, et al. Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease. Neurosci Lett. 1999;262:171-174.
10. Papassotiropoulos A, Bagli M, Kurz A, et al. A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease. Ann Neurol. 2000;47:399-403. (Pubitemid 30141856)
11. Augereau P, Garcia M, Mattei MG, et al. Cloning and sequencing of the 52K cathepsin D complementary deoxyribonucleic acid of MCF7 breast cancer cells and mapping on chromosome 11. Mol Endocrinol. 1988;2:186-192.
12. Touitou I, Capony F, Brouillet JP, Rochefort H. Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction-single strand conformational polymorphism analysis and possible consequences in cancer cells. Eur J Cancer. 1994;30A:390-394.
13. Bagnoli S, Nacmias B, Tedde A, et al. Cathepsin D polymorphism in Italian sporadic and familial Alzheimer's disease. Neurosci Lett. 2002;328:273-276.
14. Bhojak TJ, DeKosky ST, Ganguli M, Kamboh MI. Genetic polymorphisms in the cathepsin D and interleukin-6 genes and the risk of Alzheimer's disease. Neurosci Lett. 2000;288:21-24. (Pubitemid 30408429)
15. Bertram L, Blacker D, Crystal A, et al. Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies. Exp Gerontol. 2000;35:1353-1361.
16. Bertram L, Guenette S, Jones J, et al. No evidence for genetic association or linkage of the cathepsin D (CTSD) exon 2 polymorphism and Alzheimer disease. Ann Neurol. 2001;49:114-116.
17. Beyer K, Lao JI, Latorre P, Ariza A. Age at onset. An essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease. Ann N YAcad Sci. 2005;1057:260-278.
18. Blomqvist ME, Reynolds C, Katzov H, et al. Towards compendia of negative genetic association studies: an example for Alzheimer disease. Hum Genet. 2006;119:29-37.
19. Capurso C, Solfrizzi V, D'Introno A, et al. The cathepsin D gene exon 2 (C224T) polymorphism and sporadic Alzheimer's disease in European populations. J Gerontol A Biol Sci Med Sci. 2005;60:991-996.
20. Crawford FC, Freeman MJ, Schinka J, et al. The genetic association between cathepsin D and Alzheimer's disease. Neurosci Lett. 2000;289:61-65.
21. Emahazion T, Feuk L, Jobs M, et al. SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet. 2001;17:407-413.
22. Ingegni T, Nocentini G, Mariani E, et al. Cathepsin D polymorphism in Italian elderly subjects with sporadic late-onset Alzheimer's disease. Dement Geriatr Cogn Disord. 2003;16:151-155.
23. Kolsch H, Ptok U, Majores M, et al. Putative association of polymorphism in the mannose 6-phosphate receptor gene with major depression and Alzheimer's disease. Psychiatr Genet. 2004;14:97-100.
24. Majores M, Kolsch H, Bagli M, et al. Screening for new polymorphisms using single-strand conformation polymorphism analysis. Int J Mol Med. 2002;9:185-187.
25. Mateo I, Sanchez-Guerra M, Combarros O, et al. Lack of association between cathepsin D genetic polymorphism and Alzheimer disease in a Spanish sample. Am J Med Genet. 2002;114:31-33.
26. McIlroy SP, Dynan KB, McGleenon BM, Lawson JT, Passmore AP. Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease. Neurosci Lett. 1999;273:140-141.
27. Menzer G, Muller-Thomsen T, Meins W, et al. Non-replication of association between cathepsin D genotype and late onset Alzheimer disease. Am J Med Genet. 2001;105:179-182.
28. Prince JA, Feuk L, Sawyer SL, et al. Lack of replication of association findings in complex disease: an analysis of 15polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur J Hum Genet. 2001;9:437-444.
29. Styczynska M, Religa D, Pfeffer A, et al. Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease. Neurosci Lett. 2003;344:99-102.
30. Jhoo JH, Park WY, Kim KW, et al. Lack of association of cathepsin D genetic polymorphism with Alzheimer's disease in Koreans. Arch Gerontol Geriatr. 2005;41:121-127.
31. Li XQ, Chen D, Zhang ZX, Qu QM, Zhang JW. Association between cathepsin D polymorphism and Alzheimer's disease in a Chinese Han population. Dement Geriatr Cogn Disord. 2004;18:115-119. (Pubitemid 39140359)
32. Matsui T, Morikawa Y, Tojo M, et al. Cathepsin D polymorphism not associated with Alzheimer's disease in Japanese. Ann Neurol. 2001;49:544-545.
33. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat genet. 2007;39:17-23.
34. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278:1349-1356.
35. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939-944.
36. Zivelin A, Rosenberg N, Peretz H, Amit Y, Kornbrot N, Seligsohn U. Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem. 1997;43:1657-1659.
37. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472. (Pubitemid 23230526)
38. Patsopoulos NA, Tatsioni A, Ioannidis JP. Claims of sex differences: an empirical assessment in genetic associations. JAMA. 2007;298:880-893.
39. Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009;41:1088-1093.
40. Riemenschneider M, Blennow K, Wagenpfeil S, et al. The cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer's disease. Hum Mutat. 2006;27:532-537.